Explained: How Covid-19 has disrupted access to Parkinson's medication
September 23, 2020 11:33 am
The responses indicated that 88.9 per cent of those in low-income countries considered access to Parkinson’s disease medication to have been affected by Covid-19, compared with 22.8 per cent of those in high income countries.
.png)
No hay comentarios:
Publicar un comentario